Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type

被引:27
作者
Chen, WN [1 ]
Jones, D [1 ]
Medeiros, LJ [1 ]
Luthra, R [1 ]
Lin, P [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
FLT3; gene; internal tandem duplications; point mutations; acute myeloid leukaemia; cytogenetics;
D O I
10.1111/j.1365-2141.2005.05666.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FLT3 gene mutations, either internal tandem duplication or point mutation type, are common in acute myeloid leukaemia (AML). We describe 21 AML cases with both types of gene mutations, so-called dual mutations, representing approximately 1% of all cases. Most newly diagnosed AML with FLT3 dual mutations had monocytic differentiation and a normal karyotype. Over the disease course, changes in FLT3 mutation status were seen in 89% of cases, and were associated with cytogenetic changes. We conclude that FLT3 dual mutations occur rarely in AML, and appear to be related to clonal evolution.
引用
收藏
页码:726 / 728
页数:3
相关论文
共 11 条
[1]   FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group [J].
Abu-Duhier, FM ;
Goodeve, AC ;
Wilson, GA ;
Gari, MA ;
Peake, IR ;
Rees, DC ;
Vandenberghe, EA ;
Winship, PR ;
Reilly, JT .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (01) :190-195
[2]   FLT3 mutations are associated with other molecular lesions in AML [J].
Carnicer, MJ ;
Nomdedéu, JF ;
Lasa, A ;
Estivill, C ;
Brunet, S ;
Aventín, A ;
Sierra, J .
LEUKEMIA RESEARCH, 2004, 28 (01) :19-23
[3]   MULTILEVEL EFFECTS OF FLT3 LIGAND ON HUMAN HEMATOPOIESIS - EXPANSION OF PUTATIVE STEM-CELLS AND PROLIFERATION OF GRANULOMONOCYTIC PROGENITORS MONOCYTIC PRECURSORS [J].
GABBIANELLI, M ;
PELOSI, E ;
MONTESORO, E ;
VALTIERI, M ;
LUCHETTI, L ;
SAMOGGIA, P ;
VITELLI, L ;
BARBERI, T ;
TESTA, U ;
LYMAN, S ;
PESCHLE, C .
BLOOD, 1995, 86 (05) :1661-1670
[4]  
Karali V, 2002, BLOOD, V100, p197B
[5]   FLT3 in human hematologic malignancies [J].
Kiyoi, H ;
Naoe, T .
LEUKEMIA & LYMPHOMA, 2002, 43 (08) :1541-1547
[6]  
Kiyoi H, 1999, BLOOD, V93, P3074
[7]   Medical progress -: Acute myeloid leukemia [J].
Löwenberg, B ;
Downing, JR ;
Burnett, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (14) :1051-1062
[8]   Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia:: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease [J].
Schnittger, S ;
Schoch, C ;
Dugas, M ;
Kern, W ;
Staib, P ;
Wuchter, C ;
Löffler, H ;
Sauerland, CM ;
Serve, H ;
Büchner, T ;
Haferlach, T ;
Hiddemann, W .
BLOOD, 2002, 100 (01) :59-66
[9]   Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia [J].
Shih, LY ;
Huang, CF ;
Wang, PN ;
Wu, JH ;
Lin, TL ;
Dunn, P ;
Kuo, MC .
LEUKEMIA, 2004, 18 (03) :466-475
[10]   Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia:: association with FAB subtypes and identification of subgroups with poor prognosis [J].
Thiede, C ;
Steudel, C ;
Mohr, B ;
Schaich, M ;
Schäkel, U ;
Platzbecker, U ;
Wermke, M ;
Bornhäuser, M ;
Ritter, M ;
Neubauer, A ;
Ehninger, G ;
Illmer, T .
BLOOD, 2002, 99 (12) :4326-4335